Biorecognition

The research group Biorecognition investigates the molecular mechanisms behind biomolecular binding and functional response in metabolic and signal transduction pathways. We aim to investigate novel therapeutic approaches for correction of associated metabolic and neurological malfunctions.

Master's Thesis projects

Our group provides several interesting topics for the degree MSc.

Group leader

Aurora Martinez

Lab leader

Knut Teigen

Modeling ligand-induced effects

Molecular motors convert chemical energy to mechanical work in the process of carrying out their specific tasks. Often these proteins are fueled by ATP binding and hydrolysis, enabling switching between different conformations. Such motors represents interesting drug targets as they are involved in a myriad of essential biological processes. Read more at PLoS.

News

New paper on pharmacological chaperones

Researchers in Biorecognition recently published a potential therapy for the metabolic disorder methylamalonic aciduria in the journal Human Molecular Genetics.
News

Biorecognition on the cover of Proteins

Dr. Lars Skjærven (now at EMBL Heidelberg) and Professor Aurora Martinez got their publication highlighted on the October issue of Proteins.
News

Honey bee mystery protein is a freight train for health and lifespan

Heli Havukainen, a PhD student associated with Biorecognition, last week successfully defended her PhD thesis entitled "Dissecting Molecular Properties of Honey Bee Vitellogenin" at the Norwegian University of Life Sciences (UMB).
News

Biorecognition student wins international contest

Maite Bezem, a master’s student in the Biorecognition research group, was a member of the team that won the international Sci-preneurship Contest held in Brussels.
BIOMEDICINE

Long road to find a cure

Aurora Martinez has been developing a new genetic disease drug. Now she and her team have received a generous grant and are hoping to start their own company.